Trials / Completed
CompletedNCT01274403
A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Gruppo Italiano Studio Linfomi · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare efficacy and toxicity of melphalan and prednisone versus meplhalan, prednisone and Thalidomide in elderly patients with multiple myeloma or patients with multiple myeloma but not eligible for high dose treatment with stem cells support.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Melphalan, Prednisone and Thalidomide |
Timeline
- First posted
- 2011-01-11
- Last updated
- 2011-01-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01274403. Inclusion in this directory is not an endorsement.